Cross-linking of fibrinogen by factor XIIi zymogen is not apparent in vivo
Shainoff, J.R.; DiBello, P.M.
Thrombosis and Haemostasis 89(5): 943
2003
ISSN/ISBN: 0340-6245 PMID: 12719793 Document Number: 554521
Document emailed within 1 workday
Related Documents
Jirousková, M.; Smyth, S.S.; Kudryk, B.; Coller, B.S. 2001: A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis Thrombosis and Haemostasis 86(4): 1047-1056Egbring, R.; Schmidt, W.; Havemann, K. 1973: Etiology of factor XIII, factor V and fibrinogen deficiency in acute leukemias Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1351-1354
Ogawa, K.; Baba, S.; Funazaki, K.; Nakanishi, K.; Hirohashi, K.; Suzuki, E.; Tamura, M. 1984: The values of plasminogen, antithrombin III, factor XIIi and fibrinogen according to age and sex Rinsho Byori. Japanese Journal of Clinical Pathology 32(6): 679-682
Lapan, K.A.; Fay, P.J. 1998: Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking Thrombosis and Haemostasis 80(3): 418-422
Murray, D.; Jenkins, W.T.; Meyn, R.E. 1985: Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo Cancer Research 45(12 Part 1): 6446-6452
DeNeve, W.J.; Everett, C.K.; Suminski, J.E.; Valeriote, F.A. 1988: Influence of WR2721 on DNA cross-linking by nitrogen mustard in normal mouse bone marrow and leukemia cells in vivo Cancer Research 48(21): 6002-6005
Berberich, I.; Shu, G.L.; Clark, E.A. 1994: Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B Journal of Immunology 153(10): 4357-4366
Kawagoe, H. 1976: A case of congenital factor XIIi deficiency and acquired factor XIIi deficiency Rinsho Byori. Japanese Journal of Clinical Pathology 24(4): 286
Kätzel, R.; Kubel, M.; Scheel, H.; Wegner, H. 1978: Results of in vivo analysis of injected fibrinogen degradation products and factor VIIi in patients with hemophilia a Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 33(15): 525-529
Perera, L.; Darden, T.A.; Pedersen, L.G. 2001: Modeling human zymogen factor IX Thrombosis and Haemostasis 85(4): 596-603
Kloczko, J.; Zuch, A.; Bielawiec, M.; Buluk, K. 1980: Factor XIIi (FSF - fibrin stabilizing factor) in pathological states with thrombin generation Haematologica 65(5): 629-635
Rossi, A.; Argenziano, G. 1970: Factor XIIi (fibrin stabilizing factor) in various dermatological diseases (screening test) Archives d'Anatomie Microscopique et de Morphologie Experimentale 59(2): 198-201
Brandt, M.; Hofmann, K.D.; Wagner, F.; Koob, P. 1978: Effect of hormonal contraception on the fibrin-stabilizing factor (factor XIII) Zentralblatt für Gynakologie 100(17): 1089-1092
Kłoczko, J.; Zuch, A.; Bielawiec, M.; Buluk, K. 1983: Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders Acta Haematologica Polonica 14(1): 13-19
Debets, J.M.; Van de Winkel, J.G.; Ceuppens, J.L.; Dieteren, I.E.; Buurman, W.A. 1990: Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase Journal of Immunology 144(4): 1304-1310
Hung, I.J. 1980: Congenital deficiency of fibrin-stabilizing factor (factor XIII) Journal of the Formosan Medical Association 79(11): 1025-1031
Zuch, A.; Rudobielska, M.; Zwierzowa, W.; Jurgielewicz, E.; Buluk, K. 1972: Ontogenetic variability of fibrin stabilizing factor level (FSF--Factor XIII of blood coagulation system) in the plasma of healthy children Pediatria Polska 47(10): 1197-1203
Hiura, H. 2004: Fibrinogen (factor I) and dys (functional) -fibrinogen Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 597-599
Inaba, H.; Ikematsu, S. 1987: Factor XIIi Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 70: 160-166
Billon, S.; Escoffre-Barbe, M.; Mercier, B.; Abgrall, J.F.; Ferec, C. 1999: Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients Thrombosis and Haemostasis 81(4): 659-660